摘要
决奈达隆是一种多通道阻滞剂,与胺碘酮一样,兼具Ⅰ～Ⅳ类抗心律失常药物（Vaughan-Williams分类）的特性。药理学研究中,决奈达隆的电生理学和血液动力学特性与胺碘酮相似。动物模型研究显示,
出处
《临床心电学杂志》
2009年第3期203-206,共4页
Journal of Clinical Electrocardiology
参考文献10
-
1Bolderman RW,,Rob Hermans JJ,Maessen JG.Determination of the class III antiarrhythmic drugs dronedarone and amiodarone,and their principal metabolites in plasma and myocardium by high-performance liquid chromatography and UV-detection[].Journal of Chromatography B.2009
-
2Hohnloser SH,Crijns HJ,van Eickels M,et al.Effect of dronedarone on cardiovascular events in atrial fibrillation[].The New England Journal of Medicine.2009
-
3Preobrazhenski-DV.Efficacy of dronedarone in cardiac failure due to severe left ventricular systolic dysfunction.Results of the ANDROME-DA[].Kardiologiia.2008
-
4Davy JM,Herold M,Hoglund C,et al.ERATO Study Investigators.Dronedarone for the control ofventricular rate in permanent atrial fibril-lation:the Efficacy and safety of dRonedArone for the cOntrol of ven-tricular rate duringatrial fibrillation(ERATO)study[].American Heart Journal.2008
-
5Tschuppert Y,Buclin T,Rothuizen LE,et al.Effect of dronedarone on renal function in healthy subjects[].British Journal of Clinical Pharmacology.2007
-
6Damy T,Pousset F,Caplain H,et al.Pharmacokinetic and pharmaco-dynamic interactions between metoprolol and dronedarone in extensive and poor CYP2D6metabolizers healthy subjects[].Fundam Clin Phar-macol.2004
-
7Krishnamoorthy S,Lip GY.Antiarrhythmic drugs for atrial fibrillation:focus on dronedarone[].Expert Review of Cardiovascular Therapy.2009
-
8Zimetbaum PJ.Dronedarone for atrial fibrillation--an odyssey[].The New England Journal of Medicine.2009
-
9ohnloser SH,Crijns HJ,van Eickels M,et al.Effect of dronedarone on cardiovascular events in atrial fibrillation[].The New England Journal of Medicine.2009
-
10W. Sun,J.S.M. Sarma,B.N. Singh.Electrophysiological effects of dronedarone (SR33589), a non-iodinated benzofuran derivative in the rabbit heart. Comparison with amiodarone[].Circulation.1999
同被引文献5
-
1张杰,张楠,葛海涛.心房颤动治疗药物决奈达隆[J].世界临床药物,2009,30(12):765-768. 被引量：5
-
2何晓清,吴泰志,张福利,谢美华.盐酸决奈达隆合成路线图解[J].中国医药工业杂志,2010,41(2):148-151. 被引量：13
-
3顾寅明,杨臻峥.2009年获美国FDA批准上市的药物[J].药学进展,2010,34(6):288-288. 被引量：4
-
4汪玉梅,张勇,胡永亮.盐酸决奈达隆的合成[J].河北化工,2012,35(4):12-13. 被引量：5
-
5何学军,宋俊松,王德才,刘华权,朱海溪.盐酸决奈达隆的合成[J].生物加工过程,2012,10(3):67-70. 被引量：4
-
1喻志锋.服用加替沙星引起体内葡萄糖平衡异常[J].中国药师,2007,10(2):192-192.
-
2张光明,崔炜.胺碘酮作用机制的多样性[J].临床荟萃,2004,19(9):529-531. 被引量：16
-
3治心动过速常用药[J].家庭健康（医学科普）,2007(1):39-39.
-
4鲁颖,杨永杰,陈悦,王强.镉对家兔离体空肠力学特性的影响[J].劳动医学,1999,16(2):65-67. 被引量：2
-
5谢扬,李肖莉,饶邦复.胺碘酮的临床应用[J].现代医药卫生,2002,18(3):169-170. 被引量：4
-
6陈金明.胺碘酮抗心律失常的临床应用(Ⅰ)[J].药学服务与研究,2013,13(4). 被引量：2
-
7李自愚.一种多用途β-阻滞剂——甲苯甲氧苯心安[J].医药导报,1989,8(6):32-33.
-
8李士通,庄心良,屈桂莲,刘健,徐琳,孔宁.心动超声监测比较硫喷妥钠、异丙酚和依托咪酯乳剂对血液动力学的影响[J].中华麻醉学杂志,1997,17(10):613-614. 被引量：8
-
9Zemel,PC,肖江.补镁对高血压病人代谢和血液动力学的影响[J].国外医学（医学地理分册）,1991,12(3):119-120.
-
10梅叶祥.195例胺碘酮非心血管系统方面药物不良反应文献分析[J].中国实用医药,2010,5(19):148-149. 被引量：11
